Federal Court Blocks Mailing of Mifepristone, Impacting Abortion Access Nationwide
A federal appeals court has issued a ruling that prohibits the mailing of mifepristone, a widely used abortion pill, marking a significant shift in U.S. abortion policy. This decision, made by the 5th U.S. Circuit Court of Appeals, affects all states, including those without abortion restrictions, and is seen as a major victory for anti-abortion advocates. The ruling overturns regulations set by the Food and Drug Administration (FDA) that allowed the pill to be obtained via mail, a method that has been crucial for many, especially in rural areas with limited access to healthcare facilities. The decision is expected to be appealed to the U.S. Supreme Court by drug manufacturers. The ruling has sparked reactions from various stakeholders, with California Governor Gavin Newsom vowing to continue supporting abortion rights in the state. 
